Prasol Chemicals Q1 FY27 Results: Profit Rs. 61.02 Crore, IPO Expenses Noted
Prasol Chemicals reported Q1 FY27 results with profit after tax at ₹61.02 crore and total income of ₹435.36 crore. The company noted the retirement of Dr. Chitra Vaidya, Vice-President – R&D, effective September 30, 2026. IPO-related expenses of ₹3.19 crore were also disclosed.
The announcement includes unaudited quarterly results and a key personnel change, which are material information for investors. The disclosure of IPO expenses also provides important financial context.
The results are mixed, with a profit reported but also an acknowledgement of IPO-related expenses. The retirement of a key personnel is a neutral event in this context.
Prasol Chemicals Limited announced the outcome of its Board Meeting held on September 28, 2026. The Board approved the Unaudited Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report from the Statutory Auditors.
Key financial highlights for the quarter ended June 30, 2026, include total income of ₹435.36 crore and profit after tax of ₹61.02 crore. The company also noted the retirement of Dr. Chitra Vaidya, Vice-President – R&D, effective September 30, 2026. The Board Meeting commenced at 5:00 P.M. and concluded at 06:45 P.M.
The financial results are prepared in accordance with Indian Accounting Standards (IND AS). The company has incurred an expenditure of ₹31.86 million (approximately ₹3.19 crore) related to its Initial Public Offer (IPO), which is included under Other Current Assets and is proposed to be charged to the Securities Premium account upon IPO completion. The company's equity shares were listed on NSE and BSE on September 16, 2026, following a successful IPO that aggregated ₹5,000 million.
What to do with a filing like this
Prasol Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Prasol Chemicals Limited. Read the original for the full detail.